The prevention and treatment effects of egg yolk high density lipoprotein on the formation of atherosclerosis plaque in rabbits

Document Type : Original Article


1 Neurocognitive Research Center and Department of Physiology, College of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Pharmacology, College of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 Department of Physiology, College of Medicine, North Khorasan University of Medical Sciences, Bojnourd, Iran

4 Department of Pathology, College of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

5 Department of Anatomy and Cell Biology, College of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

6 Student Research Committee, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran


Objective(s): Atherosclerosis is the main leading cause of cardiovascular diseases. The purpose of this study was to assess the potential preventive effect of egg yolk HDL on the atherosclerosis plaque formation.
Materials and Methods: Thirty rabbits were divided into five groups: A; normal diet, B; hyper-cholesterolemic diet, C; hypercholesterolemic + 400 mg/kg egg yolk HDL D; hypercholesterolemic +100 mg/kg egg yolk HDL and E; 200 mg/kg egg yolk HDL. At the end of the experiment, the lipid profiles were measured by spectrophotometric method. The histological sections of thoracic aorta also were taken and analyzed under light microscope.
Results: At the end of the 2nd and the 4th weeks, there was a significant increase of cholesterol level in groups B, C, and D compared to group A (P<0.05). Following HDL treatment, triglyceride (TG) levels increased significantly versus  group A and also the TG level decreased significantly in group C, D, and E versus group B  (P<0.01). Egg yolk HDL significantly increased HDL-C in groups C, D, and E (P<0.01) compared to groups A and B (P<0.05). The surface area of the atherosclerotic plaque was increased significantly in group B versus group A (P<0.001). Egg yolk HDL consumption reduced the plaque size significantly (P<0.001).
Conclusion: Our findings indicated that treatment with egg yolk HDL increased serum HDL-C and decreased atherosclerotic plaque size in rabbits.Thus, egg yolk HDL may be considered as an anti-atherosclerotic treatment for cardiovascular diseases.


1. Ramires JAF, Chagas ACP. Panorama das doenças cardiovasculares no Brasil. In: Nobre F, Serrano CV, editores. Tratado de cardiologia SOCESP. São Paulo:Manole; 2005.p.7-46.
2. AntheaMaton. Human Biology and Health. Englewood Cliffs, NJ: Prentice Hall; 1993.p. ISBN 0-13-981176-1.
3. Navab M, Ananthramaiah GM, Reddy ST. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 2004; 45:993–1007.
4. Sala F, Luigi Catapano AL, Norata GD. High density lipoproteins and atherosclerosis: emerging aspects. J Geriatr Cardiol 2012; 9:401−407.
5. Khera AV, Cuchel M, de la Llera-MoyaM. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011; 364:127–135.
6. VonEckardstein A, Nofer JR, Assmann G. High density lipoproteins and arteriosclerosis: Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001; 21:13–27.
7. Duong M, Collins HL, Jin W. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler Thromb Vasc Biol 2006; 26:541–547.
8. Ieira P, VieiraA, Sanders E, Steyrer E, Nimpf J, Schneider W. Chicken yolk contains bona fide high density lipoprotein particles. J Lipid Res 1995; 36:601-610.
9. Masaharu K, Seiichi A. Isolation of crustacean egg yolk lipoproteins by deferential density gradient ultracentrifugation .Comp Biochem Physiol 1992; 103:363-J68.
10. Liu E, Kitajima S, Higaki Y. High lipoprotein lipase activity increases insulin sensitivity in transgenic rabbits.  Metabolism 2005; 54:132-138.
11. Gordon DJ, Rifkind BM. High density lipoprotein: the clinical implications of recent studies. N Engl J Med 1989; 321:1311–1316.
12. Robert Superko H, Lakshmana P, Paul T, Katherine M, Spencer B. Highdensity lipoprotein subclasses and their relationship to cardiovascular disease. J Clin Lipidol 2012; 6:496 -523.
13. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977; 62:707–14.
14. Miller NE, Weinstein DB, Carey TE, Koschinsky T, Steinberg D. Interaction between high density and low density lipoproteins during uptake and degradation by cultured human fibroblasts. J Clin Invest 1987; 60:78-89.
15. Castelli WP, Doyles JT, Gordon T. HDL-cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation 1977; 55:767–772.
16. Barter PJ, Caulfield M, Eriksson M, Evans GW, Kuivenhoven JA, Barter PJ, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357:2109–2122.
17. Eren E, Ellidag HY, Aydin O, Yilmaz N. HDL functionality and crystal-based sterile inflammation in atherosclerosis. Clin Chim Acta 2014; 15;439:18-23.
18. Akira M, Shin S, Wataru M , Takanori T, Fumio M , Tsuyoshi T, et al. Intravenous Iijection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1995; 15:1882-1888.
19. Andersen CJ, Blesso CN, Lee J, Barona J, Shah D, Thomas MJ, et al. Egg consumption modulates HDL lipid composition and increases the cholesterol-accepting capacity of serum in metabolic syndrome. Lipids 2013; 48:557-567.
20. Omole JO, Ighodaro OM. Comparative studies of the effects of egg yolk, oats, apple, and wheat bran on serum lipid p0rofile of wistar rats. ISRN Nutr 2013; 2013:730479.
21. Spence JD, Jenkins DJ, Davignon J. Egg yolk consumption and carotid plaque. Atherosclerosis 2012; 224:469e473.
22. Durrington PN. How HDL protects against atheroma. Lancet 1993; 342:1315–1316.
23. Reichl D, Miller NE. Pathophysiology of reverse cholesterol transport Insight from inherited disorders of lipoprotein metabolism. Arterioscler Thromb Vasc Biol 1989; 9:785–797.
24. Marcel YL, Vezina B, Teng B, Sniderman AD. Transfer of cholesterol esters between human high density lipoproteins and triglyceride rich lipoproteins controlled by a plasma protein factor. Atherosclerosis 1980; 35:127–133.
25. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34:1255-1274.
26. Yoshinari U, Keijiro S. High-density lipoprotein and atherosclerosis:    Roles of lipid transporters. World J Cardiol 2014; 6:1049-1059.
27. Saku K, Ahmad M, Glas-Greenwalt P, Kashyap ML. Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man. Thromb Res 1985; 39:1–8.
28. Satoh K, Imaizumi TA, Yoshida H, Takamatsu S. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells. J Lab Clin Med 1994; 124:225–231.
29. Mackness MI, Durrington PN. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 1995; 115:243–253.
30. Spector A, ScanuAM, Kaduce TL, Figard PH, Fless GM, Czervionke RL. Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells. J Lipid Res 1985; 26:288–297.158 B.
31. Miller NE, Forde OH, Thelle DS, Mjos OD. The tromso heart study: high density lipoprotein as a
protective factor against coronary heart disease: a prospective case control study. Lancet 1977; 1:965–967.
32. Maranhão RC, Freitas FR. HDL metabolism and atheroprotection: predictive value of lipid transfers. Adv Clin Chem 2014; 65:1-41.
33. Lamarche B, Despres JP, Pouliot MC, Prud’homme D, Moorjani S, Lupien PJ, et al. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb 1993; 13:33-40.
34. Lewis GE, Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1996; 12:37–56.